Beta-Blocker Evaluation in Survival Trial (BEST)
NCT00000560 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2016-04-14
Summary
To determine if addition of a beta-blocker to standard therapy in Class III and Class IV heart failure patients reduced total mortality.
Conditions
- Cardiovascular Diseases
- Heart Diseases
- Heart Failure, Congestive
- Heart Failure
Interventions
- DRUG
-
adrenergic beta antagonists
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Philip Lavori · Veterans Administration Hospital
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1994-06-30
- Completion
- 1999-09-30
More Related Trials
-
Eplerenone in Heart Failure Treatment
NCT02344199 ·Status: COMPLETED
-
Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure
NCT00077948 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure
NCT01120210 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 5-1058
NCT03708146 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure
NCT06299826 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines
NCT00232180 ·Status: COMPLETED ·Phase: PHASE3
-
BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF
NCT04434664 ·Status: COMPLETED ·Phase: PHASE4
-
Role of Sacubitril/Valsartan in Improving Provider Performance in Managing Heart Failure Under Medicare Alternative Payment Models
NCT05096039 ·Status: COMPLETED
-
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
NCT07181109 ·Status: RECRUITING ·Phase: PHASE3
-
ALP-1 Continuous Intravenous Infusion to Maintain Clinical Stability in Advanced Heart Failure
NCT00610051 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling
NCT00045994 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
NCT00259038 ·Status: COMPLETED ·Phase: PHASE2
-
Spironolactone Therapy in Chronic Stable Right HF Trial
NCT03344159 ·Status: COMPLETED ·Phase: PHASE4
-
The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure
NCT00082589 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)
NCT00090259 ·Status: COMPLETED ·Phase: PHASE3
-
Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure
NCT00252187 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Dietary Nitrate Supplementation on Cardiorespiratory Control in Chronic Heart Failure
NCT02401126 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF
NCT04757584 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of CLR325 in Chronic Stable Heart Failure Patients.
NCT02696967 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure
NCT05659264 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure
NCT03036124 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients With Heart Failure
NCT03387215 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
NCT00000542 ·Status: COMPLETED ·Phase: PHASE3
-
Preliminary Study on the Clinical Effect of Recombinant Human Brain Natriuretic Peptide on Sepsis Complicated With Heart Failure
NCT05111769 ·Status: UNKNOWN ·Phase: NA
-
A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction
NCT03098979 ·Status: COMPLETED ·Phase: PHASE2